AustralianSuper Pty Ltd Purchases 205,814 Shares of Colgate-Palmolive Company (NYSE:CL)

AustralianSuper Pty Ltd boosted its stake in Colgate-Palmolive Company (NYSE:CL - Free Report) by 18.1% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 1,344,469 shares of the company's stock after buying an additional 205,814 shares during the period. AustralianSuper Pty Ltd owned approximately 0.17% of Colgate-Palmolive worth $125,977,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. South Dakota Investment Council grew its position in shares of Colgate-Palmolive by 24.4% during the 1st quarter. South Dakota Investment Council now owns 25,721 shares of the company's stock worth $2,410,000 after purchasing an additional 5,050 shares in the last quarter. Resurgent Financial Advisors LLC grew its position in shares of Colgate-Palmolive by 5.8% during the 1st quarter. Resurgent Financial Advisors LLC now owns 5,278 shares of the company's stock worth $495,000 after purchasing an additional 287 shares in the last quarter. St. Louis Trust Co grew its position in shares of Colgate-Palmolive by 45.5% during the 1st quarter. St. Louis Trust Co now owns 7,419 shares of the company's stock worth $695,000 after purchasing an additional 2,319 shares in the last quarter. AMG National Trust Bank grew its position in shares of Colgate-Palmolive by 6.4% during the 1st quarter. AMG National Trust Bank now owns 9,426 shares of the company's stock worth $883,000 after purchasing an additional 564 shares in the last quarter. Finally, Auxano Advisors LLC acquired a new position in shares of Colgate-Palmolive during the 1st quarter worth approximately $432,000. Institutional investors and hedge funds own 80.41% of the company's stock.

Colgate-Palmolive Stock Down 0.4%

NYSE:CL traded down $0.36 during trading hours on Friday, reaching $86.88. The company had a trading volume of 4,973,724 shares, compared to its average volume of 4,870,195. The company has a quick ratio of 0.54, a current ratio of 0.85 and a debt-to-equity ratio of 8.96. The firm has a market cap of $70.41 billion, a price-to-earnings ratio of 24.54, a P/E/G ratio of 4.59 and a beta of 0.37. The business's 50-day simple moving average is $90.34 and its two-hundred day simple moving average is $90.38. Colgate-Palmolive Company has a twelve month low of $85.32 and a twelve month high of $109.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings data on Friday, April 25th. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.86 by $0.05. The firm had revenue of $4.91 billion during the quarter, compared to analysts' expectations of $4.92 billion. Colgate-Palmolive had a net margin of 14.52% and a return on equity of 461.04%. The business's revenue was down 3.0% on a year-over-year basis. During the same period last year, the company earned $0.86 earnings per share. On average, equities analysts expect that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 15th. Shareholders of record on Friday, July 18th will be given a $0.52 dividend. This represents a $2.08 annualized dividend and a yield of 2.39%. The ex-dividend date is Friday, July 18th. Colgate-Palmolive's dividend payout ratio is 58.76%.

Wall Street Analyst Weigh In

CL has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. upped their price target on shares of Colgate-Palmolive from $95.00 to $103.00 and gave the stock an "overweight" rating in a report on Monday, April 28th. Citigroup increased their price objective on shares of Colgate-Palmolive from $103.00 to $108.00 and gave the company a "buy" rating in a research note on Monday, April 28th. Wall Street Zen downgraded shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Wednesday, May 7th. Barclays increased their price objective on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the company an "equal weight" rating in a research note on Tuesday, July 15th. Finally, Wells Fargo & Company increased their price objective on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the company an "underweight" rating in a research note on Wednesday, April 2nd. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Hold" and an average target price of $100.64.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.